RadNet (RDNT) Competitors $56.61 -0.16 (-0.28%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$57.78 +1.17 (+2.06%) As of 05/23/2025 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RDNT vs. FMS, HIMS, OPCH, GH, BTSG, SHC, PRVA, SGRY, CON, and VCYTShould you be buying RadNet stock or one of its competitors? The main competitors of RadNet include Fresenius Medical Care (FMS), Hims & Hers Health (HIMS), Option Care Health (OPCH), Guardant Health (GH), BrightSpring Health Services (BTSG), Sotera Health (SHC), Privia Health Group (PRVA), Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), and Veracyte (VCYT). These companies are all part of the "healthcare" industry. RadNet vs. Fresenius Medical Care Hims & Hers Health Option Care Health Guardant Health BrightSpring Health Services Sotera Health Privia Health Group Surgery Partners Concentra Group Holdings Parent Veracyte Fresenius Medical Care (NYSE:FMS) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, community ranking, valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings. Is FMS or RDNT more profitable? Fresenius Medical Care has a net margin of 3.43% compared to RadNet's net margin of -0.25%. Fresenius Medical Care's return on equity of 6.04% beat RadNet's return on equity.Company Net Margins Return on Equity Return on Assets Fresenius Medical Care3.43% 6.04% 2.69% RadNet -0.25%4.29%1.45% Which has higher earnings & valuation, FMS or RDNT? Fresenius Medical Care has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFresenius Medical Care$19.49B0.87$540.07M$1.1225.87RadNet$1.87B2.27$3.04M-$0.43-131.65 Does the MarketBeat Community favor FMS or RDNT? Fresenius Medical Care received 68 more outperform votes than RadNet when rated by MarketBeat users. However, 66.05% of users gave RadNet an outperform vote while only 54.64% of users gave Fresenius Medical Care an outperform vote. CompanyUnderperformOutperformFresenius Medical CareOutperform Votes42454.64% Underperform Votes35245.36% RadNetOutperform Votes35666.05% Underperform Votes18333.95% Does the media refer more to FMS or RDNT? In the previous week, RadNet had 5 more articles in the media than Fresenius Medical Care. MarketBeat recorded 13 mentions for RadNet and 8 mentions for Fresenius Medical Care. Fresenius Medical Care's average media sentiment score of 1.58 beat RadNet's score of 1.39 indicating that Fresenius Medical Care is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive RadNet 9 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, FMS or RDNT? Fresenius Medical Care has a beta of 0.85, meaning that its share price is 15% less volatile than the S&P 500. Comparatively, RadNet has a beta of 1.46, meaning that its share price is 46% more volatile than the S&P 500. Do institutionals and insiders believe in FMS or RDNT? 8.4% of Fresenius Medical Care shares are held by institutional investors. Comparatively, 77.9% of RadNet shares are held by institutional investors. 5.1% of RadNet shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Do analysts rate FMS or RDNT? Fresenius Medical Care presently has a consensus price target of $27.80, suggesting a potential downside of 4.04%. RadNet has a consensus price target of $69.75, suggesting a potential upside of 23.21%. Given RadNet's stronger consensus rating and higher possible upside, analysts clearly believe RadNet is more favorable than Fresenius Medical Care.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fresenius Medical Care 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00RadNet 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.40 SummaryRadNet beats Fresenius Medical Care on 10 of the 19 factors compared between the two stocks. Get RadNet News Delivered to You Automatically Sign up to receive the latest news and ratings for RDNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RDNT vs. The Competition Export to ExcelMetricRadNetMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$4.25B$2.91B$5.34B$8.31BDividend YieldN/A31.24%5.27%4.10%P/E Ratio-808.6012.8526.9619.61Price / Sales2.27157.68396.61135.08Price / Cash18.8157.5638.3234.64Price / Book4.804.276.774.50Net Income$3.04M-$22.21M$3.24B$248.60M7 Day Performance-7.41%-1.39%0.27%-0.88%1 Month Performance12.21%-2.77%6.59%7.89%1 Year Performance-3.30%5.02%18.46%8.60% RadNet Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RDNTRadNet3.3987 of 5 stars$56.61-0.3%$69.75+23.2%-3.3%$4.25B$1.87B-808.608,970News CoveragePositive NewsAnalyst DowngradeFMSFresenius Medical Care3.125 of 5 stars$29.11+1.1%$27.80-4.5%+36.3%$17.08B$19.49B24.06123,200News CoveragePositive NewsAnalyst ForecastHIMSHims & Hers Health2.3381 of 5 stars$62.35-3.6%$37.67-39.6%+225.4%$13.96B$1.78B141.71650Trending NewsAnalyst UpgradeOPCHOption Care Health4.4391 of 5 stars$33.09-0.4%$35.50+7.3%+8.2%$5.42B$5.19B27.815,600Positive NewsGHGuardant Health4.6353 of 5 stars$40.24-1.1%$52.32+30.0%+48.9%$4.99B$774.00M-11.301,790Positive NewsBTSGBrightSpring Health Services1.6087 of 5 stars$24.11-1.3%$23.56-2.3%+105.2%$4.20B$11.86B-92.7335,000Positive NewsSHCSotera Health2.9793 of 5 stars$12.74-0.5%$15.80+24.0%+8.6%$3.62B$1.11B50.963,000Positive NewsPRVAPrivia Health Group3.7043 of 5 stars$25.010.0%$27.38+9.5%+32.1%$3.05B$1.80B250.13810SGRYSurgery Partners2.803 of 5 stars$23.60-1.4%$34.75+47.2%-10.2%$3.02B$3.17B-49.1712,200CONConcentra Group Holdings ParentN/A$22.54-0.8%$28.50+26.4%N/A$2.87B$1.93B16.8211,000Positive NewsEx-DividendVCYTVeracyte3.9491 of 5 stars$29.00-0.7%$40.90+41.0%+30.6%$2.27B$463.39M-193.33790Positive News Related Companies and Tools Related Companies Fresenius Medical Care Alternatives Hims & Hers Health Alternatives Option Care Health Alternatives Guardant Health Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives Privia Health Group Alternatives Surgery Partners Alternatives Concentra Group Holdings Parent Alternatives Veracyte Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RDNT) was last updated on 5/25/2025 by MarketBeat.com Staff From Our PartnersGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredTrump’s Bitcoin Reserve is No Accident…Bitcoin's supply is being drained at unprecedented rates, but while most investors focus solely on Bitcoin, th...Crypto 101 Media | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RadNet, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RadNet With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RDNT Stock Free RDNT Stock Alerts